封面
市场调查报告书
商品编码
1612803

心臟监测与心律管理市场:按产品、最终用户划分 - 全球预测 2025-2030 年

Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices), End-User (Ambulatory Center, Home Healthcare, Hospitals) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

心臟监测和心律管理市场2023年估值为198亿美元,预计到2024年将达到207.4亿美元,复合年增长率为4.91%,预计到2030年将达到277.1亿美元。

心臟监测和心律管理市场包括各种旨在诊断、管理和治疗心血管疾病的设备和技术。由于心臟疾病仍然是全球发病的主要原因之一,因此需要持续监测患者和有效的疾病管理,这凸显了对这些解决方案的需求。应用包括心律不整监测、远端患者监护和术后护理,主要最终用途是医院、诊所和门诊手术中心。关键的成长要素包括心血管疾病的盛行率不断上升、医疗保健领域的物联网和人工智慧等技术进步,以及个人主动管理健康意识的提高。此外,对家庭医疗保健解决方案的需求和远端医疗服务的扩展导致远端监控设备的快速采用,创造了巨大的成长机会。然而,设备成本高、法规结构复杂、报销场景有限等挑战可能会阻碍市场扩张。企业需要透过专注于具有成本效益的解决方案和安全的监管途径来驾驭这些动态。利用巨量资料分析来改善预测诊断并提高不同监控系统之间的互通性是存在机会的。可提高准确性和患者舒适度的可穿戴技术创新可以提供显着的竞争优势。旨在使设备小型化同时保持效率的研究和开发工作也很有希望。此外,我们有潜力透过扩大与医疗保健提供者的伙伴关係和促进综合护理服务来开拓新的细分市场。市场的本质是高度动态的,其特点是快速的技术转变和对以患者为中心的解决方案的强烈关注。寻求发展的公司专注于整合先进的分析,透过使用者友好的介面加强患者的依从性,并不断评估不断变化的医疗保健环境,以跟上不断变化的消费者需求和不断变化的监管环境。避免这样做。

主要市场统计
基准年[2023] 198亿美元
预测年份 [2024] 207.4亿美元
预测年份 [2030] 277.1亿美元
复合年增长率(%) 4.91%

市场动态:快速发展的心臟监测和心律管理市场的关键市场洞察

心臟监测和节律管理市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 老年人口增加及心血管疾病发生率增加
    • 有利的政府法规和 CRM 报销的可用性
    • 提高早期诊断和预防保健的意识
  • 市场限制因素
    • 与心臟监测和节律管理设备相关的高成本
  • 市场机会
    • 人们对穿戴式心臟监测设备的兴趣日益浓厚
    • 持续开发先进心臟设备
  • 市场挑战
    • 缺乏具有心电图和心律专业知识的熟练专业人员

波特五力:引领心臟监测与心律管理市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解心臟监测和心律管理市场的外部影响

外部宏观环境因素在塑造心臟监测和心律管理市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟监测和心律管理市场的竞争格局

对心臟监测和节律管理市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟监测与心律管理市场供应商的绩效评估

FPNV定位矩阵是评估心臟监测和心律管理市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製心臟监测和心律管理市场的成功之路

对于希望加强在全球市场的影响力的公司来说,对心臟监测和心律管理市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口增加及心血管疾病发生率增加
      • 有利的 CRM 政府法规和报销制度
      • 提高对早期诊断和预防性保健措施的认识
    • 抑制因素
      • 与心臟监测和节律管理设备相关的高成本
    • 机会
      • 对穿戴式心臟监测设备的兴趣日益增长
      • 先进心臟设备的开发正在进行中
    • 任务
      • 缺乏具有心电图和心率专业知识的熟练专业人员
  • 市场区隔分析
    • 产品:增加心臟监测设备在治疗心臟相关疾病的使用
    • 最终使用者:高级护理医院对心臟监测和节律管理的强烈需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心臟监测与心律管理市场:副产品

  • 心臟监测装置
    • 心电图
      • 心电图监测
      • 静态心电图
      • 压力心电图
    • 心臟超音波图
    • 心臟事件记录器
    • 嵌入式循环录音机
    • 移动心电遥测
  • 心率管理装置
    • 心臟去颤器
      • 体外去颤心臟去颤器
      • 自动体外电击器
      • 手动体外电击器
      • 心臟去颤器
      • 植入式心臟整流去颤器
      • S-ICD
      • T-ICD
    • 循环录音机
    • 心律调节器
      • 外部的
      • 凹入式

第七章心臟监测与心律管理市场:依最终使用者分类

  • 门诊中心
  • 家庭保健
  • 医院

第八章美洲心臟监测与心律管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太心臟监测与心律管理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的心臟监测和心律管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • Abbott Assert-IQ 心臟监测仪获得 CE 标誌核准,用于增强心率管理
    • FDA核准Medtronic创新 Aurora EV-ICD 系统
    • 心臟监测的进展:波士顿科学公司 (Boston Scientific) 的 LUX-Dx II+ ICM 系统简介
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACS Diagnostics by Applied Cardiac Systems Inc.
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • Baxter International Inc.
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Koninklijke Philips NV,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Qardio, Inc.
  • Schiller AG
  • Spandan
  • Tricog Health
  • Zoll Medical Corporation
Product Code: MRR-B812DD579A84

The Cardiac Monitoring & Cardiac Rhythm Management Market was valued at USD 19.80 billion in 2023, expected to reach USD 20.74 billion in 2024, and is projected to grow at a CAGR of 4.91%, to USD 27.71 billion by 2030.

The cardiac monitoring and cardiac rhythm management market encompasses a broad range of devices and technologies aimed at diagnosing, managing, and treating cardiovascular disorders. As cardiac diseases remain among the leading causes of morbidity globally, the necessity for these solutions is underscored by the need for continuous patient monitoring and efficient disease management. The application scope includes arrhythmia monitoring, remote patient monitoring, and post-operative care, catering to hospitals, clinics, and ambulatory surgical centers as primary end-use segments. Key growth influencers include the increasing prevalence of cardiovascular diseases, technological advancements like IoT and AI in healthcare, and rising awareness among individuals regarding proactive health management. Additionally, the adoption of remote monitoring devices has surged, driven by the demand for home healthcare solutions and the expansion of telemedicine services, presenting a significant growth opportunity. However, challenges such as high device costs, the complexity of regulatory frameworks, and limited reimbursement scenarios can impede market expansion. Companies must navigate these dynamics by focusing on cost-effective solutions and robust navigation of regulatory pathways. Opportunities lie in leveraging big data analytics for improved predictive diagnostics and enhancing interoperability among diverse monitoring systems. Innovating wearable technology with better accuracy and patient comfort could provide significant competitive advantages. Emphasizing R&D efforts toward miniaturization of devices while maintaining efficiency also holds promise. Further, expanding partnerships with healthcare providers to facilitate integrated care delivery could unlock new market segments. The nature of the market is highly dynamic, characterized by rapid technological shifts and a strong emphasis on patient-centered solutions. Businesses aiming for growth should concentrate on integrating advanced analytics, enhancing patient compliance through user-friendly interfaces, and continuously assessing the evolving healthcare landscape to keep abreast of shifting consumer demands and regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 19.80 billion
Estimated Year [2024] USD 20.74 billion
Forecast Year [2030] USD 27.71 billion
CAGR (%) 4.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Monitoring & Cardiac Rhythm Management Market

The Cardiac Monitoring & Cardiac Rhythm Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population and incidence of cardiovascular diseases
    • Favorable government regulations and availability of reimbursement for CRM
    • Growing awareness towards early diagnosis and preventive healthcare measures
  • Market Restraints
    • High cost associated with cardiac monitoring and rhythm management devices
  • Market Opportunities
    • Increasing proclivity for wearable cardiac monitoring devices
    • Ongoing development for advanced cardiac devices
  • Market Challenges
    • Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Monitoring & Cardiac Rhythm Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Monitoring & Cardiac Rhythm Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Monitoring & Cardiac Rhythm Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Monitoring & Cardiac Rhythm Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Monitoring & Cardiac Rhythm Management Market

A detailed market share analysis in the Cardiac Monitoring & Cardiac Rhythm Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Monitoring & Cardiac Rhythm Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Monitoring & Cardiac Rhythm Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Monitoring & Cardiac Rhythm Management Market

A strategic analysis of the Cardiac Monitoring & Cardiac Rhythm Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Monitoring & Cardiac Rhythm Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics by Applied Cardiac Systems Inc., Alivecor, Inc., Asahi Kasei Corporation, Baxter International Inc., Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Spandan, Tricog Health, and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Monitoring & Cardiac Rhythm Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Monitoring Devices and Cardiac Rhythm Management Devices. The Cardiac Monitoring Devices is further studied across ECG, Echocardiogram, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry. The ECG is further studied across Holter Monitors, Resting ECG, and Stress ECG. The Cardiac Rhythm Management Devices is further studied across Defibrillators, Loop Recorders, and Pacemaker. The Defibrillators is further studied across External Defibrillator and Implantable Cardioverter Defibrillators. The External Defibrillator is further studied across Automatic External Defibrillator, Manual External Defibrillator, and Wearable Cardioverter Defibrillator. The Implantable Cardioverter Defibrillators is further studied across S-ICD and T-ICD. The Pacemaker is further studied across External and Implantable.
  • Based on End-User, market is studied across Ambulatory Center, Home Healthcare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population and incidence of cardiovascular diseases
      • 5.1.1.2. Favorable government regulations and availability of reimbursement for CRM
      • 5.1.1.3. Growing awareness towards early diagnosis and preventive healthcare measures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with cardiac monitoring and rhythm management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing proclivity for wearable cardiac monitoring devices
      • 5.1.3.2. Ongoing development for advanced cardiac devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of cardiac monitoring devices for treating heart-related conditions
    • 5.2.2. End-User: High need for cardiac monitoring & cardiac rhythm management across hospitals for providing advanced care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Monitoring & Cardiac Rhythm Management Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Monitoring Devices
    • 6.2.1. ECG
      • 6.2.1.1. Holter Monitors
      • 6.2.1.2. Resting ECG
      • 6.2.1.3. Stress ECG
    • 6.2.2. Echocardiogram
    • 6.2.3. Event Monitors
    • 6.2.4. Implantable Loop Recorders
    • 6.2.5. Mobile Cardiac Telemetry
  • 6.3. Cardiac Rhythm Management Devices
    • 6.3.1. Defibrillators
      • 6.3.1.1. External Defibrillator
      • 6.3.1.1.1. Automatic External Defibrillator
      • 6.3.1.1.2. Manual External Defibrillator
      • 6.3.1.1.3. Wearable Cardioverter Defibrillator
      • 6.3.1.2. Implantable Cardioverter Defibrillators
      • 6.3.1.2.1. S-ICD
      • 6.3.1.2.2. T-ICD
    • 6.3.2. Loop Recorders
    • 6.3.3. Pacemaker
      • 6.3.3.1. External
      • 6.3.3.2. Implantable

7. Cardiac Monitoring & Cardiac Rhythm Management Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Center
  • 7.3. Home Healthcare
  • 7.4. Hospitals

8. Americas Cardiac Monitoring & Cardiac Rhythm Management Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott's Assert-IQ Cardiac Monitor Receives CE Mark Approval for Enhanced Heart Rhythm Management
    • 11.3.2. FDA Approves Medtronic's Innovative Aurora EV-ICD System
    • 11.3.3. Advancements in Cardiac Monitoring: The Introduction of Boston Scientific's LUX-Dx II+ ICM System
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics by Applied Cardiac Systems Inc.
  • 3. Alivecor, Inc.
  • 4. Asahi Kasei Corporation
  • 5. Baxter International Inc.
  • 6. Biotronik SE & Co KG
  • 7. Boston Scientific Corporation
  • 8. BPL Medical Technologies Private Limited
  • 9. GE Healthcare
  • 10. HeartFlow Holding, Inc.
  • 11. Koninklijke Philips N.V.,
  • 12. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 13. Medtronic PLC
  • 14. Microport Scientific Corporation
  • 15. Nihon Kohden Corporation
  • 16. Qardio, Inc.
  • 17. Schiller AG
  • 18. Spandan
  • 19. Tricog Health
  • 20. Zoll Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY RESTING ECG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STRESS ECG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MOBILE CARDIAC TELEMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AUTOMATIC EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY S-ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY T-ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PACEMAKER, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY ECG, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANC